Oxycontin Tablet, Film Coated, Extended Release
NDC Package 59011-430-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Oxycontin (oxycodone hydrochloride) tablets is a medication used to help relieve severe ongoing pain (such as due to cancer). This formulation utilizes a tablet, film coated, extended release delivery system. Marketed by Knoa Pharma Llc, this product is identified by NDC 59011-430 and is authorized under FDA application NDA022272.

Identification & Billing

NDC Package Code
59011-430-10
Package Description
100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE
Product Code
59011-430
11-Digit Billing Format
59011043010
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA
RxNorm Crosswalk
  • RxCUI: 1049504 - OxyCONTIN 10 MG 12HR Extended Release Oral Tablet
  • RxCUI: 1049504 - Abuse-Deterrent 12 HR oxycodone hydrochloride 10 MG Extended Release Oral Tablet [Oxycontin]
  • RxCUI: 1049504 - 12 HR Oxycontin 10 MG Extended Release Oral Tablet
  • RxCUI: 1049504 - OxyContin 10 MG 12 HR Extended Release Oral Tablet
  • RxCUI: 1049545 - OxyCONTIN 15 MG 12HR Extended Release Oral Tablet

Clinical Specifications

Proprietary Name
Oxycontin
Non-Proprietary Name
Oxycodone Hydrochloride
Substance Name
Oxycodone Hydrochloride
Dosage Form
Tablet, Film Coated, Extended Release - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer; the tablet is formulated in such manner as to make the contained medicament available over an extended period of time following ingestion.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
OXYCODONE HYDROCHLORIDE 30 mg/1
Pharmacologic Class
Usage Information
This medication is used to help relieve severe ongoing pain (such as due to cancer). Oxycodone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. The higher strengths of this drug (more than 40 milligrams per tablet) should be used only if you have been regularly taking moderate to large amounts of an opioid pain medication. These strengths may cause overdose (even death) if taken by a person who has not been regularly taking opioids. Do not use the extended-release form of oxycodone to relieve pain that is mild or that will go away in a few days. This medication is not for occasional ("as needed") use.
DEA Schedule
Schedule II (CII) Substances

Regulatory & Marketing

Labeler Name
Knoa Pharma Llc
Product Type
Human Prescription Drug
FDA Application #
NDA022272
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
08-08-2010
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (59011-430). Click a package code to view its specific billing and regulatory data.

59011-430-20
2 BLISTER PACK in 1 CARTON / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 59011-430-10 identifies a specific commercial package of 100 tablet, film coated, extended release in 1 bottle of Oxycontin, a human prescription drug labeled by Knoa Pharma Llc. This tablet, film coated, extended release is formulated for oral use and contains oxycodone hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Knoa Pharma Llc on August 08, 2010. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

This medication is used to help relieve severe ongoing pain (such as due to cancer). Oxycodone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. The higher strengths of this drug (more than 40 milligrams per tablet) should be used only if you have been regularly taking moderate to large amounts of an opioid pain medication. These strengths may cause overdose (even death) if taken by a person who has not been regularly taking opioids. Do not use the extended-release form of oxycodone to relieve pain that is mild or that will go away in a few days. This medication is not for occasional ("as needed") use.

How is this Knoa Pharma Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 59011043010. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
59011-430-10
11-Digit CMS (5-4-2)
59011-0430-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.